Literature DB >> 20824569

Prevalence, correlates, and self-management of HIV-related depressive symptoms.

L S Eller1, E H Bunch, D J Wantland, C J Portillo, N R Reynolds, K M Nokes, C L Coleman, J K Kemppainen, K M Kirksey, I B Corless, M J Hamilton, P J Dole, P K Nicholas, W L Holzemer, Y-F Tsai.   

Abstract

Depressive symptoms are highly prevalent yet undertreated in people living with HIV/AIDS (PLHAs). As part of a larger study of symptom self-management (N=1217), this study examined the prevalence, correlates, and characteristics (intensity, distress, and impact) of depressive symptoms, and the self-care strategies used to manage those symptoms in PLHAs in five countries. The proportion of respondents from each country in the total sample reporting depressive symptoms in the past week varied and included Colombia (44%), Norway (66%), Puerto Rico (57%), Taiwan (35%), and the USA (56%). Fifty-four percent (n=655) of the total sample reported experiencing depressive symptoms in the past week, with a mean of 4.1 (SD 2.1) days of depression. Mean depression intensity 5.4 (SD 2.7), distressfulness 5.5 (SD 2.86), and impact 5.5 (SD 3.0) were rated on a 1-10 scale. The mean Center for Epidemiologic Studies Depression Scale score for those reporting depressive symptoms was 27 (SD 11; range 3-58), and varied significantly by country. Respondents identified 19 self-care behaviors for depressive symptoms, which fell into six categories: complementary therapies, talking to others, distraction techniques, physical activity, medications, and denial/avoidant coping. The most frequently used strategies varied by country. In the US sample, 33% of the variance in depressive symptoms was predicted by the combination of education, HIV symptoms, psychological and social support, and perceived consequences of HIV disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20824569     DOI: 10.1080/09540121.2010.498860

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  18 in total

Review 1.  A review of the use of complementary and alternative medicine and HIV: issues for patient care.

Authors:  Ava Lorenc; Nicola Robinson
Journal:  AIDS Patient Care STDS       Date:  2013-09       Impact factor: 5.078

2.  Quality of life in HIV-infected Chinese women and their family caregivers: an intervention study.

Authors:  Wei-Ti Chen; Chengshi Shiu; Joyce P Yang; Kerong Wang; Lin Zhang; Jing Zhang; Nancy R Reynolds; Holly Powell Kennedy; Kaveh Khoshnood; Li-Chen Chen; Meijuan Bao; Hongxin Zhao; Hongzhou Lu
Journal:  AIDS Care       Date:  2018-08-15

3.  A randomized controlled trial of an HIV/AIDS Symptom Management Manual for depressive symptoms.

Authors:  Lucille S Eller; Kenn M Kirksey; Patrice K Nicholas; Inge B Corless; William L Holzemer; Dean J Wantland; Suzanne S Willard; Linda Robinson; Mary Jane Hamilton; Elizabeth F Sefcik; Shahnaz Moezzi; Marta Rivero Mendez; Maria Rosa; Sarie Human
Journal:  AIDS Care       Date:  2012-08-13

4.  Depressive symptoms and antiretroviral therapy (ART) initiation among HIV-infected Russian drinkers.

Authors:  Tracie M Goodness; Tibor P Palfai; Debbie M Cheng; Sharon M Coleman; Carly Bridden; Elena Blokhina; Evgeny Krupitsky; Jeffrey H Samet
Journal:  AIDS Behav       Date:  2014-06

5.  The Effect of FAmily-CEntered (FACE®) Pediatric Advanced Care Planning Intervention on Family Anxiety: A Randomized Controlled Clinical Trial for Adolescents With HIV and Their Families.

Authors:  Christopher J Lin; Yao I Cheng; Patricia A Garvie; Lawrence J D'Angelo; Jichuan Wang; Maureen E Lyon
Journal:  J Fam Nurs       Date:  2020-11       Impact factor: 3.818

6.  Interaction of paroxetine with mitochondrial proteins mediates neuroprotection.

Authors:  Joseph P Steiner; Muznabanu Bachani; Brett Wolfson-Stofko; Myoung-Hwa Lee; Tongguang Wang; Tonguang Wang; Guanhan Li; Wenxue Li; David Strayer; Norman J Haughey; Avindra Nath
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

7.  Self-Management Strategies for Coping with Adverse Symptoms in Persons Living with HIV with HIV Associated Non-AIDS Conditions.

Authors:  Sarah Iribarren; Karolynn Siegel; Sabina Hirshfield; Susan Olender; Joachim Voss; Joseph Krongold; Heidi Luft; Rebecca Schnall
Journal:  AIDS Behav       Date:  2018-01

8.  The prevalence and patterns of substance use by birth cohort among HIV-positive adults in Florida.

Authors:  Zachary L Mannes; Vaughn E Bryant; Larry E Burrell; Huiyin Lu; Erin G Ferguson; Zhi Zhou; Robert L Cook; Nicole Ennis
Journal:  Aging Ment Health       Date:  2018-02-13       Impact factor: 3.658

9.  Escitalopram population pharmacokinetics in people living with human immunodeficiency virus and in the psychiatric population: Drug-drug interactions and probability of target attainment.

Authors:  Perrine Courlet; Monia Guidi; Anaïs Glatard; Susana Alves Saldanha; Matthias Cavassini; Thierry Buclin; Catia Marzolini; Chin B Eap; Laurent A Decosterd; Chantal Csajka
Journal:  Br J Clin Pharmacol       Date:  2019-07-07       Impact factor: 4.335

10.  Self-compassion and risk behavior among people living with HIV/AIDS.

Authors:  Carol Dawson Rose; Allison Webel; Kathleen M Sullivan; Yvette P Cuca; Dean Wantland; Mallory O Johnson; John Brion; Carmen J Portillo; Inge B Corless; Joachim Voss; Wei-Ti Chen; J Craig Phillips; Lynda Tyer-Viola; Marta Rivero-Méndez; Patrice K Nicholas; Kathleen Nokes; Jeanne Kemppainen; Elizabeth Sefcik; Lucille Sanzero Eller; Scholastika Iipinge; Kenn Kirksey; Puangtip Chaiphibalsarisdi; Nancy Davila; Mary Jane Hamilton; Dorothy Hickey; Mary Maryland; Paula Reid; William L Holzemer
Journal:  Res Nurs Health       Date:  2014-02-09       Impact factor: 2.228

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.